ProShare Advisors’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

ProShare Advisors’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,111	Closed	-$204K	–	2318
2024 Q3	$204K	Buy	+6,111	New	+$210K	﹤0.01%	1720

ProShare Advisors's LBPH Position: Q4 2024 in Review

ProShare Advisors sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 6,111 shares — an estimated $204K sold.

ProShare Advisors first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $204K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

ProShare Advisors reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
ProShare Advisors sold 6,111 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $204K.
ProShare Advisors first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
ProShare Advisors's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $204K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.